Neuraxpharm Holdco Iberia SL has 1,139 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 4.9%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. The company has more than 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira. Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com
As of September 2025
Neuraxpharm Holdco Iberia
workforce metrics
Headcount
1.1k
Avg. Salary
$58k
Tenure
4.5yr
Growth Rate
4.9%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Neuraxpharm Holdco Iberia annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Neuraxpharm Holdco Iberia annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?